Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Clinical Trials
419 Articles Available
1
18
Can't find what you're looking for? Try our
advanced search
.
Clinical Trial Logistics
Expediting Clinical Trials with A Global Transportation Footprint and Clinical Packaging
PAP-Q3-19-CL-037
Investment in Innovation
Should You Choose a Commercial HPAPI Manufacturer for Your Clinical Program?
PAO-11-2019-CL-001
Translational Pharmaceutics
Measuring the Time and Cost Benefits of Integrated Product Development
PAP-Q4-19-CL-017
Clinical Results
ACADIA Pharmaceuticals Presents Positive Top-line Results from Dementia-Related Psychosis Trial
PR-M12-19-NI-012
Capacity Expansion
PCI Unveils Expanded Clinical Center in Midwest
PR-M12-19-NI-006
Cell and Gene Therapy
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001® for Severe Hemoglobinopathies
PR-M11-19-NI-023
Clinical Results
VistaGen Reports Topline Phase 2 Results for AV-101 as an Adjunctive Treatment of Major Depressive Disorder
PR-M11-19-NI-019
Drug Development
WuXi Biologics Congratulates Tychan on the World’s First Yellow Fever Antibody Tested Safe and Efficacious in Human Volunteers
PR-M11-19-NI-018
Clinical Trials
Kayentis Opens Japanese Subsidiary to Support Growth of Asia-Pacific Clinical Trials Sector
PR-M11-19-NI-016
Partner
Revolution Medicines and Amgen Partner on Phase 1b Study to Evaluate Combination of RMC-4630 and AMG 510
PR-M11-19-NI-004
FDA
Compugen Announces FDA Clearance of IND Application for COM902
PR-M11-19-NI-003
Clinical Trials
Ichnos Sciences Announces Completion of Enrollment of Phase 2b Trials for Two Investigational Therapies - ISB 830 and ISC 27864
PR-M11-19-NI-002
Endpoints
Sanifit Announces the Phase 2b CaLIPSO Trial of SNF472 Met Endpoint in Slowing the Cardiovascular Calcification in Patients on Hemodialysis
PR-M10-19-NI-051
Clinical Results
TG Therapeutics Announces Positive Results from the UNITY-NHL Phase 2b Pivotal Trial Evaluating Umbralisib Monotherapy in Patients with Relapsed/Refractory Follicular Lymphoma
PR-M10-19-NI-042
Clinical Data
Mirati Therapeutics Presents First Clinical Data of Phase 1/2 Trial of MRTX849
PR-M10-19-NI-043
Clinical Trials
Managing the Complexities of International Clinical Trials
PAP-Q3-19-CL-037
Worldwide Clinical Trials
The Relevance of Global Clinical Trials
PAP-Q3-19-NI-002
FDA Guidance
Updating Ethical Guidelines for Cancer Clinical Trials
PAP-Q3-19-NI-006
Pediatric
TrialSpark Announces Collaboration with Limbix on Conducting an End-to-End Clinical Trial on Limbix's Digital Therapeutic for Adolescent Depression
PR-M10-19-NI-034
Clinical Trials
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis
PR-M10-19-NI-017
Clinical Trial Partnership
Parexel and Datavant Enter Multi-Year Strategic Partnership to Enable the Connection of Real-World Data Across All Parexel Clinical Trials
PR-M10-19-NI-014
Clinical Trials
Sosei Heptares Notes the Announcement of Positive Results from Phase III IRIDIUM Study of Inhaled Combination QVM149 in Patients with Uncontrolled Asthma
PR-M10-19-NI-011
FDA
FDA Encourages Inclusion of Male Patients in Breast Cancer Clinical Trials
PR-M10-19-NI-005
Clinical Trials
Poorly Reported Placebos May Lead to Mistaken Estimates of Benefits
PR-M10-19-NI-004
1
18
»
